［1］THRELFALL EJ, HAMPTONMD, Chart H, et al. Use of plasmid profile typing for surveillance of salmonella enteritidis phage type 4 from humans, poultry and eggs［J］. Epidemiol Infect，1994，112（1）：25-31.

［2］PERFECT JR, MAGEE BB, MAGEE PT. Separation of chromosomes of cryptococcus neoformans by pulsed field gel electrophoresis［J］. Infect Immun, 1989, 57 (9): 2624-2627.

［3］PERFECT JR, KETABCHI N, CoxGM, et al. Karyotyping of cryptococcus neoformans as an epidemiological tool［J］. J Clin Microbiol, 1993, 31 (12): 3305-3309.

［4］LEKA, LI Y, XU X, et al. Alterations in fecal Lactobacillus and Bifidobacterium species in type 2 diabetic patients in southern china population［J］. Front Physiol, 2013, 3: 496.

［5］TELENTI A, MARCHESI F, BALZ M, et al. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis［J］. J. Clin. Microbiol, 1993, 31 (2): 175-178.

［6］AMOLD BL, ITAKURA K, ROSSI JJ, et al. PCR-based quantitation of low levels of HIV-1 DNA by using an external standard［J］. Genet Anal Tech Appl, 1992, 9 (4): 113-116.

［7］DIVIACCO S, NORIO P, ZENTILIN L, et al. A novel procedure for quantitative polymerase chain reaction by coamplification of competitive templates［J］. Gene, 1992, 122 (2): 313-320.

［8］HAGIWARA H, HAYASHI N, MITA E, et al. Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease［J］. Hep atology, 1993, 17 (4): 545-550.

［9］THRELFALLEJ, HAMPTON MD, CHART H, et al Use of plasmid profile typing for surveillance of Salmonella enteritidis phage type 4 from humans, poultry and eggs［J］. Epidemiol Infect，1994，112（1）：25-31.

［10］SANO T, SMITH CL, CANTOR CR, et al. Immuno-PCR: very sensitive antigen detect ion by means of specific antibody-DNA conjugates［J］. Science, 1992, 258 (5079): 120-122.

［11］MAIA M, TAKAHASHI H, ADLER K, et al. Development of a two-site immuno-PCR as say for hepatitis B surface antigen［J］. J Virol Methods, 1995, 52 (3): 273-286.

［12］NUOVO GJ. Questioning in situ PCR. In situ cDNA polymerase chain reaction：A novel technique for detecting mRNA expression［J］. AmJPathol，1994，145（3）：741.

［13］BAGASRA O, SESHAMMA T, POMERANTZ RJ. Polymerase chain reaction in situ: intracellular amplification and detection of HIV-1 proviral DNA and other speci fic genes［J］. J Immunol Methods, 1993, 158: 131.

［14］PREVOT S, RAPHAELM, FOURNIERJG, et al. Detection by in situ hybridization of HIV and c-myc RNA in tumour cells of AIDS-related B-cell lymphomas［J］. Histopathology, 1993, 22 (2): 151-156.

［15］COBB BD, CLARKSON JM. A simple procedure for optimising the polymerase chain reaction（PCR）using modified Taguchi methods［J］. Nucleic Acids Res，1994，22（18）：3801-3805.

［16］SMITHSON SL, IPATERSON IC, BAILEY AM, et al. Cloning and characterisation of a gene encoding a cuticle-degrading protease from theinsect pathogenic fungus Metarh izium anisopliae［J］. Gene, 1995, 166 (1): 161-165.

［17］TARKKA E, AHMAN H, SIITONEN A. Ribotyping as an epidemiologic tool for Escherichia coli［J］. EpidemiolInfect, 1994, 112 (2): 263-274.

［18］WONG, NA, LINTON CJ, JALALH, et al. Randomly amplified polymorphic DNA typing: a useful tool for rapid epidemiological typing of Klebsiella pneumoniae［J］. Epidemiol Infect, 1994, 113 (3): 445-454.

［19］WILBER JC. Branched DNA for quantification of viral load. Immunol Invest，1997，26（1-2）：9-13.

［20］HAYASHI J, YOSHIMURA E, KISHIHARA Y, et al. Hepatitis C virus RNA levels determined by branched DNA probe assay correlated with levels assessed using competitive PCR［J］. Am J Gastroenterol, 1996, 91 (2): 314-318.

［21］HARDIE DR, KANNEMEYER J, STANNARD LM, et al. DNA single strand conformation polymor phism identifies five defined strains of hepatitis B virus (HBV) during an outbreak of HBV infection in an oncology unit［J］. J Med Virol, 1996, 49 (1): 49-54.

［22］CHA TA, ZHAO J, LANE E, et al. Determination of the genome composition of influenza virus reassortants using multiplex reverse transcriptionpolymerase chain reaction followed by fluorescent singlestrand conformation polymorphism analysis［J］. Anal Biochem, 1997, 252 (1): 24-32.

［23］MIKOLA H, HEDLOF E. Syntheses of europiumlabeled digoxin derivatives and their use in time-resolved fluoroimmunoassay［J］. Steroids，1994，59（8）：472-478.

［24］CHRISTOPOULOSTK, DIAMANDISEP, Wilson G. Quantification of nucleic acids on nitrocellulose membranes with timeresolved fluorometry［J］. Nucleic Acids Res, 1991, 19 (21): 6015-6019.

［25］SUZUKI K, MIZOKAMI M, LAU JY, et al. Confirmation of hepatitis C virus transmission through needlestick accidents by molecular evolutionary analysis［J］. J Infect Dis, 1994, 170 (6): 1575-1578.

［26］KONDO Y, MIZOKAMI M, NAKANO T, et al. Prevalence and molecular epidemiology of GB virus C/hepatitis G virus infection in Mongolia［J］. J Med Virol, 1997, 52 (2): 143-148.

［27］ARAUZ-RUIZ P, NORDER H, VISONA KA, et al. Molecular epidemiology of hepatitis B virus in Central America reflected in the genetic variability of the small S gene［J］. J Infect Dis, 1997, 176 (4): 851-858.

［28］曹经瑗，毕胜利，李景源，等.丙型肝炎病毒基因组部分NS5区蛋白基因在大肠杆菌中的表达［J］.病毒学报，1995，11（1）：21-26.

［29］BUMGARNER R. Overview of DNA microarrays：types, applications and their future.Current protocols in molecular biology. 2013，0 22：Unit-22. 1.

［30］ZHAO X, TANG YG, WU SV, et al. The Global Transcriptional Response of Isolated Human Islets of Langerhans to Glucagon-Like Peptide-1 Receptor Agonist Liraglutide［J］. ISRN Endocrinol. 2012, 2012: 608672.

［31］HUDELIST G, PACHER-ZAVISIN M, SINGER CF, et al. Use of high throughput protein array for profiling of differentially expressed proteins in normal and malignant breast tissue.Breast Cancer Res Treat［J］. 2004, 86 (3): 281-291.

［32］VANMETER AJ, RODRIGUEZ AS, BOWMAN ED, et al. Laser capture microdissection and protein microarray analysis of human non-small cell lung cancer: differential epidermal growth factor receptor (EGPR) phosphorylation events associated with mutated EGFR compared with wild type［J］. Mol Cell Proteomics, 2008, 7 (10): 1902-1924.

［33］CATER J, WIEDENHEFTB. Snapshot: CRISPR-RNA-guided adaptive immune system［J］. Cell, 163 (1): 260.

［34］JACKSON RN, WIEDENHEGT B. A conserved structural chassis for mounting versatile CRISPR RNA-guided immune responses［J］. Mol Cell, 2015, 58 (2), 722-728.

［35］STEPHEN A. The PCR Revolution：basic technologies and applications［M］. Bustin：Cambridge University Press，2009.

［36］BUNDYJG, DAVEYMP, VIANTMR. Environmental metabolomics: acritical review and future perspectives［J］. Metabolomics, 2009, 5 (1): 3-21.

［37］CHEN B, LIU YL, SHEN YM, et al. Protein microarrays in proteome-wide applications［J］. J Proteomics Bioinform, 2014, S12: 001.

［38］STERNBERG SH, DOUDNA JA. Expanding the Biologist’s Toolkit with CRISPR-Cas9［J］. Mol Cell, 2015, 58 (4): 568-574.

［39］ABDALLAH SD, STEPHEN WS, ROBERT AH. Implications for copy-number variation in the human genome: a time for questions［J］. Nat Rev Genet, 2006, 7: 414.

［40］FEUK L, CARSON AR, SCHERER SW. Structural variation in the human genome［J］.Nat Rev Genet, 2006, 7 (2): 85-97.

［41］SOLINAS-TOLDO S, LAMPEL S, STILGENBAUER S, et al. Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosomes Cancer, 1997, 20 (4): 399-407.

［42］PINKEL D, SEGRAVES R, SUDAR D, et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays［J］. Nat Genet, 1998, 20 (2): 207-211.

［43］XIE C, TAMMI MT. CNV-seq, a new method to detect copy number variation using high-throughput sequencing［J］. BMC Bioinformatics, 2009, 10 (8): 80.

［44］GREEN S, LANDERS M, LOUW J, et al. A next generation sequencing (NGS) genome wide copy number variation (CNV) assay for comparison of circulating tumor cell (CTC) heterogeneity［J］. Cancer Res, 2015, 75 (15 Suppl): 4843.

［45］MENARD V, EAP O, HARVEY M, et al. Copy-number variations (CNVs) of the human sex steroid metabolizing genes UGT2B17 and UGT2B28 and their associations with a UGT2B15 functional polymorphism［J］. Hum Mutat, 2009, 30 (9): 1310-1319.

［46］BUMGARNER R. Overview of DNA microarrays：types, applications, and their future［J］. Curr Protoc Mol Biol，2013，Chapter 22：Unit 22. 1.

［47］FANTROUSSI S, AGATHOSSN, PIEPERDH, et al. Biological assessment and remediation of contaminated sediments. 2007.

［48］BULOTTA A, PERFETTI R, HUI H, et al. GLP-1 stimulates glucose-derived de novo fatty acid synthesis and chain elongation during cell differentiation and insulin release［J］. J Lipid Res, 2003, 44 (8): 1559-1565.

［49］CAI Y, CHEN L, KANGT, et al. Prediction model with a combination of variables for diagnosis of lung cancer［J］. Med Sci Monit, 2017, 23: 5620-5629.